HJLR Mar/Apr 2019

56 MAR / APR 2019 I  Healthcare Journal of LITTLE ROCK The Arkansas Neuroscience Insti- tute’s (ANI) Cavernous Sinus Treatment program is one of the few places in the world where cavernous sinus tumors are no longer considered inoperable. Instead, the ANI Team is able to provide treatment for these tumors and hope to the patient. The cavernous sinus’deep location and complex anatomy has driven surgeons away from performing surgery on tumors such as me- ningiomas, chordomas, and hemangiomas that can grow in the cavernous sinus and has even been called a “no man’s land” of neurosurgery. Our team of skilled surgeons, led by Dr. Ali Krisht, has made surgery of the cavern- ous sinus simple as they developed new techniques to control the bleeding from the sinus, preserving the anatomical and vascular structures involved converting this “no man’s land” area to one where surgeons can safely extract these tumors with mini- mal deficits to the patient. column neurology Making the Inoperable Areas of the Brain At CHI St. Vincent’s Arkansas Neuroscience Institute, we have developed the most advanced treatment for cav- ernous sinus patients. We are one of the few places in the world where microsurgical cures for secreting pituitary adenomas of the cavernous sinus have been achieved. When you come to CHI St. Vincent, you will see a multi- disciplinary team that will provide the best treatment in a positive environment. Operable